All posts by Nikolas Dietis
Dr. Nikolas Dietis, BSc, BSc(Hons), MRes, PhD, is an advocate for the integration of innovative technologies in medical education and is a member of the Technology Enhanced Learning special interest group at the Association for the Study of Medical Education (ASME). He has a particular interest in the dynamic integration of generative-AI tools in Medical Education for improving teaching practices & enhancing learning efficiency. Dr Dietis is also a passionate science communicator, with a vigorous public outreach profile through newspaper articles, interviews and social media posts, that aim to engage the general public with evidence-based drug science, and he is also the producer of the DrugTalk podcast. Dr Dietis is an Assistant Professor of Pharmacology and the head of the Experimental Pharmacology Laboratory at the Medical School of the University of Cyprus. His current research interests revolve around translational drug discovery & repurposing using target-based and disease-oriented high-throughput screenings against in vitro & in vivo assays (zebrafish) for cancer & neurological diseases.
Author
-
Dr. Nikolas Dietis, BSc, BSc(Hons), MRes, PhD, is an advocate for the integration of innovative technologies in medical education and is a member of the Technology Enhanced Learning special interest group at the Association for the Study of Medical Education (ASME). He has a particular interest in the dynamic integration of generative-AI tools in Medical Education for improving teaching practices & enhancing learning efficiency. Dr Dietis is also a passionate science communicator, with a vigorous public outreach profile through newspaper articles, interviews and social media posts, that aim to engage the general public with evidence-based drug science, and he is also the producer of the DrugTalk podcast. Dr Dietis is an Assistant Professor of Pharmacology and the head of the Experimental Pharmacology Laboratory at the Medical School of the University of Cyprus. His current research interests revolve around translational drug discovery & repurposing using target-based and disease-oriented high-throughput screenings against in vitro & in vivo assays (zebrafish) for cancer & neurological diseases.

LLMs: Fighting Fire with Fire
Using LLM tools to tackle AI-driven science misinformation head-on